Initial Statement of Beneficial Ownership (3)
October 30 2018 - 4:44PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Braslyn Ltd.
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
10/26/2018
|
3. Issuer Name
and
Ticker or Trading Symbol
Esperion Therapeutics, Inc. [ESPR]
|
(Last)
(First)
(Middle)
CAY HOUSE, EP TAYLOR DRIVE N7776, LYFORD CAY
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
___
X
___ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
NEW PROVIDENCE, C5
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
1401000
|
D
(1)
|
|
Common Stock
|
1201250
|
D
(2)
|
|
Common Stock
|
100
|
D
(3)
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Call Option
|
10/25/2018
|
3/15/2019
|
Common Stock
|
100000
|
$50.00
|
D
(2)
|
|
Call Option
|
10/25/2018
|
3/15/2019
|
Common Stock
|
70000
|
$60.00
|
D
(2)
|
|
Explanation of Responses:
|
(1)
|
These securities are owned directly by Braslyn Ltd. ("Braslyn"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC ("Boxer Capital"), (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) Tuesday Thirteen Inc. ("Tuesday Thirteen") and (v) Joseph C. Lewis (collectively, the "Boxer Group"), and indirectly by Joseph C. Lewis. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein.
|
(2)
|
These securities are owned directly by Boxer Capital and indirectly by Boxer Management and Joseph C. Lewis.
|
(3)
|
These securities are owned directly by Tuesday Thirteen and indirectly by Joseph C. Lewis.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Braslyn Ltd.
CAY HOUSE
EP TAYLOR DRIVE N7776, LYFORD CAY
NEW PROVIDENCE, C5
|
|
X
|
|
|
Boxer Asset Management Inc.
CAY HOUSE
EP TAYLOR DRIVE N7776, LYFORD CAY
NEW PROVIDENCE, C5
|
|
X
|
|
|
Tuesday Thirteen Inc.
CAY HOUSE,
EP TAYLOR DRIVE N7776, LYFORD CAY
NEW PROVIDENCE, C5
|
|
X
|
|
|
LEWIS JOSEPH
CAY HOUSE
EP TAYLOR DRIVE N7776, LYFORD CAY
NEW PROVIDENCE, C5
|
|
X
|
|
|
Boxer Capital, LLC
11682 EL CAMINO REAL, SUITE 320
SAN DIEGO, CA 92130
|
|
X
|
|
|
Signatures
|
Braslyn Ltd., By: /s/ Joseph C. Lewis, Director
|
|
10/30/2018
|
**
Signature of Reporting Person
|
Date
|
Boxer Capital, LLC, By: /s/ Aaron I. Davis, Chief Executive Officer
|
|
10/30/2018
|
**
Signature of Reporting Person
|
Date
|
Boxer Asset Management Inc., By: /s/ Jason C. Callender, Director
|
|
10/30/2018
|
**
Signature of Reporting Person
|
Date
|
Tuesday Thirteen Inc., By: /s/ Joseph C. Lewis, Director
|
|
10/30/2018
|
**
Signature of Reporting Person
|
Date
|
/s/ Joseph C. Lewis
|
|
10/30/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024